Veeva Systems Management
Management criteria checks 4/4
Veeva Systems' CEO is Peter Gassner, appointed in Jan 2007, has a tenure of 19.42 years. total yearly compensation is $470.83K, comprised of 100% salary and 0% bonuses, including company stock and options. directly owns 7.55% of the company’s shares, worth $2.00B. The average tenure of the management team and the board of directors is 2.2 years and 6.8 years respectively.
Key information
Peter Gassner
Chief executive officer
US$470.8k
Total compensation
| CEO salary percentage | 100.00% |
| CEO tenure | 19.4yrs |
| CEO ownership | 7.6% |
| Management average tenure | 2.2yrs |
| Board average tenure | 6.8yrs |
Recent management updates
Recent updates
Narrative Update • Jun 15
VEEV: AI Execution And CRM Wins Will Support Future Multiple Reacceleration
Narrative Update The analyst price target for Veeva Systems in this framework is updated from about $263 to about $245, as analysts balance solid Q1 execution and raised guidance with AI disruption risk, CRM competition from Salesforce, and questions around the quality and mix of recent upside, particularly in services. Analyst Commentary Recent research on Veeva Systems reflects a split view, with most analysts acknowledging solid Q1 execution and raised guidance, but debating how much weight to give AI disruption risk, CRM competition, and the quality of services driven upside when thinking about valuation, execution, and long term growth.Narrative Update • Jun 01
VEEV: AI Moat And CRM Commitments Will Support Future Multiple Reacceleration
Narrative Update The analyst price target for Veeva Systems has been trimmed by about $2 to $262.68 as analysts factor in compressed software multiples, while largely maintaining their underlying growth, margin, and P/E assumptions. Analyst Commentary Recent research on Veeva Systems clusters around strong reported execution in Q4, tempered by valuation resets tied to compressed software multiples and longer term questions around AI and CRM competition.Seeking Alpha • May 29
Veeva Systems: Patience Required
Summary Veeva faces a critical Q1 earnings report after a 29% YTD share decline, with growth stabilization and AI progress in focus. VEEV's transition from Salesforce to Vault CRM and expansion of Crossix and the AI-driven Falcon platform are key strategic pivots. Guidance implies confidence: Q1 revenue $855–$858M, FY27 revenue $3.585–$3.60B, 44% margin, and strong free cash flow yield at 5.6%. Remain on the sidelines until clear signs of growth reacceleration; price target scenarios range from $127 to $210, depending on growth trajectory. Read the full article on Seeking AlphaNarrative Update • May 11
VEEV: AI Moat And CRM Commitments Will Support Premium Multiple
Veeva Systems' updated analyst price target edges lower to about $264 from roughly $265, as analysts keep their broadly positive take on the company's recent Q4 results but adjust valuation assumptions to reflect compressed software multiples and ongoing debates around AI, R&D growth, and CRM stability. Analyst Commentary Recent research on Veeva reflects a mix of optimism about execution in Q4 and caution around valuation and longer term growth drivers.Narrative Update • Apr 25
VEEV: AI Moat And Subscription Resilience Will Support Premium Multiple
Analysts have trimmed the Veeva Systems price target slightly, with the model fair value moving from about $270.93 to $264.46, as modestly lower assumed future P/E multiples more than offset largely unchanged growth and margin expectations. Analyst Commentary Recent Street research around Veeva Systems shows a split view, with many firms trimming price targets while still pointing to solid execution and specific areas of uncertainty that could influence the valuation over time.Narrative Update • Apr 08
VEEV: AI And Subscription Resilience Will Support Premium Software Multiple
Analysts trimmed the blended Veeva Systems price target by aligning with sector wide software multiple compression, even as they point to strong Q4 execution, resilient subscription growth, and an emerging AI and product pipeline as key longer term supports. Analyst Commentary Recent Street research around Veeva Systems reflects a mix of optimism on execution and growth, alongside more cautious views on competitive risk, AI impact, and valuation.Narrative Update • Mar 25
VEEV: AI Adoption In R&D Workflows Will Support Durable Premium Outlook
Analysts have adjusted their price targets on Veeva Systems into a roughly $190 to $317 range, generally trimming prior targets by tens of dollars as software valuation multiples compress, even after what they describe as solid Q4 results and broadly constructive longer term fundamentals. Analyst Commentary Recent research paints a mixed but generally constructive picture for Veeva Systems, with most firms trimming price targets while still pointing to solid execution and durable fundamentals.Narrative Update • Mar 11
VEEV: AI Adoption And CRM Commitments Will Support Durable Premium Outlook
We are trimming our Veeva Systems fair value estimate to $270.93 from $302.60, as analysts broadly reset price targets in response to sector wide software multiple compression and slightly more measured assumptions for revenue growth, margins, and future P/E multiples, despite generally solid Q4 results and guidance. Analyst Commentary Street research on Veeva Systems has become more mixed, with many firms cutting price targets while still acknowledging solid Q4 execution and robust profitability.Narrative Update • Feb 25
VEEV: AI Execution And CRM Stability Will Support Durable Premium Outlook
Our fair value estimate for Veeva Systems has edged down from $308.63 to $302.60. This reflects a series of reduced Street price targets as analysts weigh maturing products, competitive pressures, software sentiment, and the balance of growth opportunities against current valuation.Narrative Update • Feb 10
VEEV: Roche Commitment And CRM Retention Will Support Durable Premium Outlook
Our analyst fair value estimate for Veeva Systems has been trimmed slightly to $308.63. This reflects a modest reset in Street price targets as analysts balance concerns about slower growth in maturing products and competitive pressure with ongoing strengths in areas like Crossix, AI adoption, and large CRM wins such as Roche.
New Narrative • Jan 28
Rising Life Sciences Cloud Standardization And AI Adoption Will Support Strong Long Term Upside
Catalysts About Veeva Systems Veeva Systems provides cloud based software, data and consulting services to life sciences companies across commercial, R&D and manufacturing functions. What are the underlying business or industry changes driving this perspective?Narrative Update • Jan 27
VEEV: Roche Rollout And CRM Retention Will Support Durable Premium Outlook
The analyst price target embedded in our Veeva Systems model edges slightly lower to about US$310 from roughly US$311. This reflects a blend of more cautious views on growth and competitive pressure, along with offsetting positive views on durable margins, CRM customer retention, and newer areas such as Crossix and early AI traction.Narrative Update • Jan 12
VEEV: Roche Expansion And CRM Migrations Will Support Durable Premium Outlook
Analysts have trimmed their fair value estimate for Veeva Systems by about US$1 to US$310.98, reflecting modest adjustments to discount rate and growth assumptions while still pointing to what they see as durable growth drivers such as pharma CRM migrations, broader Vault adoption and newer areas like Crossix and AI. Analyst Commentary Recent Street research on Veeva Systems reflects a mix of optimism and caution, with differing views clustering around the durability of growth in CRM and Vault, the timing of pharma migrations, and how current valuation stacks up against execution and contract wins.Narrative Update • Dec 19
VEEV: Roche Commitment And CRM Migrations Will Likely Sustain Premium Outlook
Analysts have modestly trimmed their blended price target for Veeva Systems to about $312 from roughly $321, reflecting a slightly higher discount rate and lower implied future multiple, even as they highlight accelerating CRM migrations, including Roche's global Vault CRM rollout, and improving long term growth and margin expectations. Analyst Commentary Street research remains broadly constructive on Veeva Systems, with recent target changes reflecting a recalibration of software multiples rather than a material shift in company specific fundamentals.Analysis Article • Dec 03
Veeva Systems' (NYSE:VEEV) Performance Is Even Better Than Its Earnings Suggest
Investors were underwhelmed by the solid earnings posted by Veeva Systems Inc. ( NYSE:VEEV ) recently. We have done...Narrative Update • Nov 11
VEEV: Continued Momentum And New Commitments Will Likely Sustain Premium Outlook
Analysts have significantly raised their price targets on Veeva Systems, with recent updates moving targets as high as $380. They cite the company's strong sales growth prospects and solid momentum, driven by accelerating CRM customer commitments and new partnerships.Narrative Update • Oct 27
Pharma Wins And New Partnerships Will Drive Cloud Momentum In Coming Quarters
Veeva Systems' analyst price target saw a significant increase, rising by more than $80 to reflect higher expectations for sales growth and ongoing customer commitments. Analysts cited the company’s strengthening position in CRM and positive momentum across key pharma relationships.Narrative Update • Oct 13
IQVIA Resolution And Embedded AI Will Expand Digital Healthcare Cloud
Narrative Update on Veeva Systems: Analyst Price Target Revision Analysts have raised their fair value estimate for Veeva Systems to approximately $321 per share, up by nearly $4. They cited stronger than expected sales momentum, driven by new major customer commitments and continued growth in key business segments.Narrative Update • Aug 29
Data Cloud Expansion And AI Efficiencies Will Drive Future Success
Analysts have raised their price target for Veeva Systems to $314.71, citing strong Q2 “beat and raise” results, momentum in both Commercial and R&D segments, successful Vault CRM rollouts with major pharma clients, and ongoing market share gains in life sciences CRM. Analyst Commentary Bullish analysts highlighted Veeva's strong “beat and raise” Q2 results, with both subscription and services revenues growing solidly year-over-year, driven by performance in both Commercial and R&D technology segments.Analysis Article • Jul 11
If EPS Growth Is Important To You, Veeva Systems (NYSE:VEEV) Presents An Opportunity
The excitement of investing in a company that can reverse its fortunes is a big draw for some speculators, so even...Seeking Alpha • Apr 17
Veeva Systems: Substantially Overvalued As Growth Slows
Summary Veeva Systems is overvalued, trading at frothy levels despite only ~10% growth, and facing a potential slowdown in 2025; I recommend a sell rating. The company excels in the life sciences vertical with unique solutions but its ambitious revenue targets (doubling revenue by 2030) may be tough to achieve organically. Valuation multiples are high at ~10 EV/FY26 revenue and ~30x FY26 P/E, well above a number of peers - some of which are growing even faster than Veeva. Read the full article on Seeking AlphaSeeking Alpha • Mar 19
Veeva Systems: Staying Buy Rated As VEEV Is Executing Well
Summary I reaffirm my buy rating on Veeva Systems due to strong 4Q25 results, driven by R&D growth and positive Vault CRM adoption traction. VEEV's revenue grew 14% y/y to $721 million, beating expectations, with significant margin improvements and a strong balance sheet. Vault CRM added 20 new customers, with multiple top 20 pharma commitments expected in 2025, signaling positive transition progress. Data Cloud segment shows strong momentum, with new initiatives like Pulse expected to drive further CRM adoption and growth. Read the full article on Seeking AlphaSeeking Alpha • Mar 07
Veeva Systems: Solid Q4 With Margin Expansion
Summary I reiterate my “Strong Buy” rating on Veeva Systems Inc. with a one-year target price of $275 per share due to strong CRM migration and margin improvement. Veeva reported 14.3% revenue growth and 28.7% adjusted operating profit growth, driven by robust CRM adoption and billing growth. Management's guidance for FY26 includes $3.04-$3.055 billion in revenue, with anticipated 12% revenue growth despite high-interest rate challenges. I foresee continued margin expansion and revenue growth recovery to 16% by FY27 for VEEV, supported by CRM migration and easing capital funding challenges. Read the full article on Seeking AlphaSeeking Alpha • Jan 28
Veeva Systems: Forget The Short-Term Volatility; The Long Term Is Promising
Summary I rate Veeva Systems as a 'Buy' due to its strong performance recovery, despite competition from Salesforce and industry uncertainties under Trump's administration. VEEV's migration to its own CRM, Veeva Vault, is a long-term tailwind, enhancing its ecosystem and competitive edge. The Company's Q3 2025 results exceeded expectations, with significant revenue, net income, and free cash flow growth, raising FY 2025 guidance. Despite short-term volatility, Veeva's specialization in life sciences, strong balance sheet, and innovative culture position it well for long-term growth. Read the full article on Seeking AlphaSeeking Alpha • Dec 06
Veeva Systems Q3: Making Progress With Vault CRM; Reiterating 'Strong Buy'
Summary Veeva Systems shows strong growth with 13.4% revenue and 30% adjusted operating income increases, driven by successful Vault CRM migration and new customer acquisitions. The company is expanding AI offerings within Vault CRM, including CRM Bot, GenAI assistant, and Voice Control, enhancing customer experience and retention. VEEV's FY25 revenue growth is projected at over 15%, with a one-year target price of $270 per share, supported by a stable funding environment. Despite a one-time revenue recognition impact due to TFC rights, Veeva's long-term outlook remains positive, reinforcing my 'Strong Buy' rating. Read the full article on Seeking AlphaSeeking Alpha • Oct 08
Veeva Systems: Too Much Needs To Go Right, For Bull Case
Summary I appreciate Veeva Systems’ strong cash position and debt-free balance sheet, which provide stability and strategic flexibility. I recognize Veeva’s leadership in life sciences software, offering specialized solutions that streamline R&D and commercial operations. I see the migration to Vault CRM as a pivotal moment for the company, but I am wary of customer resistance that could impact growth. I acknowledge that Veeva’s path to higher profitability hinges on flawless execution, making it a high-risk, high-reward scenario. Read the full article on Seeking AlphaSeeking Alpha • Sep 24
Veeva Systems: SMB Sector Is Growing Momentum
Summary I rate Veeva Systems Inc. as a buy due to the recent 0.5% interest rate cut from the FED, boosting demand from recovering SMB biotech firms. Veeva's Q2 FY2025 results exceeded expectations, with revenue reaching $676 million and subscription revenue hitting $561 million, ensuring stable free cash flow. Improved FY2025 guidance, with revenue and non-GAAP operating earnings projections slightly raised, is positively influencing market sentiment. Veeva's revenue growth of 18.8% YoY and net income growth of 7.38% YoY demonstrate profitable expansion, supporting a strong long-term investment thesis. Read the full article on Seeking AlphaCEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Apr 30 2026 | n/a | n/a | US$942m |
| Jan 31 2026 | US$471k | US$471k | US$909m |
| Oct 31 2025 | n/a | n/a | US$860m |
| Jul 31 2025 | n/a | n/a | US$810m |
| Apr 30 2025 | n/a | n/a | US$781m |
| Jan 31 2025 | US$172m | US$446k | US$714m |
| Oct 31 2024 | n/a | n/a | US$666m |
| Jul 31 2024 | n/a | n/a | US$615m |
| Apr 30 2024 | n/a | n/a | US$556m |
| Jan 31 2024 | US$421k | US$421k | US$526m |
| Oct 31 2023 | n/a | n/a | US$567m |
| Jul 31 2023 | n/a | n/a | US$540m |
| Apr 30 2023 | n/a | n/a | US$519m |
| Jan 31 2023 | US$392k | US$392k | US$488m |
| Oct 31 2022 | n/a | n/a | US$396m |
| Jul 31 2022 | n/a | n/a | US$394m |
| Apr 30 2022 | n/a | n/a | US$412m |
| Jan 31 2022 | US$350k | US$350k | US$427m |
| Oct 31 2021 | n/a | n/a | US$433m |
| Jul 31 2021 | n/a | n/a | US$424m |
| Apr 30 2021 | n/a | n/a | US$409m |
| Jan 31 2021 | US$346k | US$346k | US$380m |
| Oct 31 2020 | n/a | n/a | US$343m |
| Jul 31 2020 | n/a | n/a | US$329m |
| Apr 30 2020 | n/a | n/a | US$314m |
| Jan 31 2020 | US$325k | US$325k | US$301m |
Compensation vs Market: Peter's total compensation ($USD470.83K) is below average for companies of similar size in the US market ($USD14.60M).
Compensation vs Earnings: Peter's compensation has been consistent with company performance over the past year.
CEO
Peter Gassner (61 yo)
19.4yrs
Tenure
US$470,833
Compensation
Mr. Peter P. Gassner Co-Founder of Veeva Systems Inc. in 2007 and has been its Chief Executive Officer since January 2007 and serves as its Director. From 2003 to 2005, Mr. Gassner served as Senior Vice Pr...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Founder | 19.4yrs | US$470.83k | 7.55% $ 2.0b | |
| President & Chief of Staff | 2.2yrs | US$4.06m | 0.016% $ 4.3m | |
| President & Chief Customer Officer | 2.2yrs | US$5.36m | 0.014% $ 3.6m | |
| Chief Financial Officer | 1.8yrs | US$2.22m | 0.0049% $ 1.3m | |
| Senior VP | 13.8yrs | US$3.41m | 0.0022% $ 589.2k | |
| Chief Accounting Officer | less than a year | no data | 0.0016% $ 437.9k | |
| Chief Information Officer | less than a year | no data | no data | |
| Director of Investor Relations | no data | no data | no data | |
| Chief People Officer | 8.4yrs | no data | no data | |
| Executive Vice President of Strategy & Campaign Manager | 9.2yrs | no data | no data | |
| President of CRM Suite | no data | no data | no data | |
| EVP & General Manager of Vault Products | no data | no data | no data |
2.2yrs
Average Tenure
56yo
Average Age
Experienced Management: VEEV's management team is considered experienced (2.2 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Founder | 19.4yrs | US$470.83k | 7.55% $ 2.0b | |
| Independent Director | 11.9yrs | US$301.76k | 0.0094% $ 2.5m | |
| Independent Chairman of the Board | 18.1yrs | US$351.85k | 0.41% $ 109.2m | |
| Independent Director | 4.4yrs | US$341.72k | 0.0037% $ 976.7k | |
| Independent Director | 9.4yrs | US$321.74k | 0.0080% $ 2.1m | |
| Independent Director | 6.8yrs | US$311.89k | 0.0044% $ 1.2m | |
| Independent Director | 6.4yrs | US$301.76k | 0.22% $ 58.3m | |
| Independent Director | 4.4yrs | US$311.89k | 0.0040% $ 1.1m | |
| Independent Director | 4.4yrs | US$311.89k | 0.0022% $ 573.3k |
6.8yrs
Average Tenure
61yo
Average Age
Experienced Board: VEEV's board of directors are considered experienced (6.8 years average tenure).
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2026/06/17 10:03 |
| End of Day Share Price | 2026/06/17 00:00 |
| Earnings | 2026/04/30 |
| Annual Earnings | 2026/01/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Veeva Systems Inc. is covered by 44 analysts. 28 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Joseph Vruwink | Baird |
| Saket Kalia | Barclays |
| Sean Dodge | BMO Capital Markets Equity Research |